Generation of gene-corrected isogenic controls from Parkinson's disease patient iPSC lines carrying the pathogenic SNCA p.A53T variant

Abstract excerpt

Pathogenic variants in the alpha-synuclein (SNCA) gene cause familial forms of Parkinson's disease (PD). Here, we describe generation of six isogenic controls from iPS cell lines derived from two PD disease patients carrying the SNCAp.A53T variant. The controls were created using CRISPR/Cas9 technology and are available for use by the PD research community to study A53T-related synucleinopathies.

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Autism Spectrum Disorder Research
• Share to CRISPR and Genetic Engineering
• Share to Parkinson's Disease Mechanisms and Treatments